Detalhe da pesquisa
1.
Tryptophan-75 Is a Low-Energy Channel-Gating Residue that Facilitates Substrate Egress/Access in Cytochrome P450 2D6.
Drug Metab Dispos
; 49(3): 179-187, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33376147
2.
Rolapitant Is a Reversible Inhibitor of CYP2D6.
Drug Metab Dispos
; 47(6): 567-573, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30952677
3.
Disruption of tubular Flcn expression as a mouse model for renal tumor induction.
Kidney Int
; 88(5): 1057-69, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26083655
4.
Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas.
Proc Natl Acad Sci U S A
; 108(4): 1439-44, 2011 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-21220347
5.
Deregulation of E2-EPF ubiquitin carrier protein in papillary renal cell carcinoma.
Am J Pathol
; 178(2): 853-60, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21281817
6.
Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer.
Proc Natl Acad Sci U S A
; 106(31): 12909-14, 2009 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-19567831
7.
Evaluation of sex-specific gene expression in archived dried blood spots (DBS).
Int J Mol Sci
; 13(8): 9599-9608, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22949818
8.
Fumarate hydratase inactivation in renal tumors: HIF1α, NRF2, and "cryptic targets" of transcription factors.
Chin J Cancer
; 31(9): 413-20, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22776233
9.
Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response.
PLoS Genet
; 4(9): e1000176, 2008 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-18773095
10.
Kinase targets in renal-cell carcinomas: reassessing the old and discovering the new.
Lancet Oncol
; 11(6): 571-8, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20381423
11.
Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
BMC Cancer
; 10: 196, 2010 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20462447
12.
Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy.
BJU Int
; 106(1): 62-5, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20002663
13.
MicroRNA profiling of human kidney cancer subtypes.
Int J Oncol
; 35(1): 109-14, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19513557
14.
Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma.
Cancer Res
; 67(7): 3171-6, 2007 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17409424
15.
A comparison study reveals important features of agreement and disagreement between summarized DNA and RNA data obtained from renal cell carcinoma.
Mutat Res
; 657(1): 77-83, 2008 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-18790077
16.
Experimental approaches to microarray analysis of tumor samples.
Biochem Mol Biol Educ
; 36(2): 149-52, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21591181
17.
A molecular classification of papillary renal cell carcinoma.
Cancer Res
; 65(13): 5628-37, 2005 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15994935
18.
Gene expression profiling in kidney cancer: combining differential expression and chromosomal and pathway analyses.
Clin Genitourin Cancer
; 5(3): 227-31, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17239277
19.
Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles.
Cancer Res
; 64(12): 4117-21, 2004 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15205321
20.
Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features.
Cancer Res
; 62(22): 6598-605, 2002 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12438255